UGT1A1 and gastric cancer: Several studies showed that UGT1A1 polymorphisms (homozygous or double heterozygous UGT1A1*6/*28) is associated with delayed metabolism of SN-38, and this leads to enhanced irinotecan-induced toxicity in various tumors including gastric cancer [10–13].